S2 Ep15: Practical Considerations for Small Cell Lung Cancer Therapeutic Options

In the third part of a 4-part series on small cell lung cancer (SCLC), CancerNetwork spoke with Wade Iams, MD, a thoracic medical oncologist at the Vanderbilt University Medical Center. The conversation focused on the toxicities of treatment options, quality of life for patients, and how Iams suggests managing and mitigating those events for individuals with SCLC. Some of the agents and regimens discussed include lurbinectedin and trilaciclib, as well as chemotherapy and immunotherapy.
Don’t forget to subscribe to the "Oncology Peer Review On-The-Go" podcast on Apple Podcasts, Spotify, or anywhere podcasts are available.
Check out the previous podcast episodes in this series:·      Episode 1: First-Line Therapeutic Options in Small Cell Lung Cancer ·      Episode 2: Treatment Options for Relapsed/Refractory Small Cell Lung Cancer